In theory, the prescription of medication compensating the deregulation of molecular pathways should lead to better treatment of cancer. However, in a multicentre phase II study in France, this approach did not render longer periods of progression-free survival. The results, published in The Lancet, raise concerns about the implementation of personalised medicine in cancer. Continue reading
Showing articles tagged with 'Cancer Therapy'
Scientists of the Hubrecht Institute, part of the Royal Dutch Academy of Science (KNAW), and the Wellcome Trust Sanger Institute, a British research centre for genetics, have developed a 3D model for colon cancer. According to their publication in Cell, the model mimics the original tumour so accurately, it can predict which cancer therapy will work in the patient. Continue reading